Molecular Biology Reports, Год журнала: 2025, Номер 52(1)
Опубликована: Март 3, 2025
Язык: Английский
Molecular Biology Reports, Год журнала: 2025, Номер 52(1)
Опубликована: Март 3, 2025
Язык: Английский
Molecular Carcinogenesis, Год журнала: 2025, Номер 64(3), С. 552 - 564
Опубликована: Янв. 6, 2025
ABSTRACT A‐to‐I RNA editing is a pervasive mechanism in the human genome that affects regulation of gene expression and closely associated with pathogenesis numerous diseases. This study elucidates regulatory edited miR‐1304‐3p esophageal squamous cell carcinoma (ESCC). Western blot, immunohistochemistry, RT‐qPCR assays were employed to quantify protein mRNA expression. Colony formation, Edu, wound healing, Transwell applied determine miRNA function. Glycolysis was assessed using glucose uptake lactate production assay. A dual‐luciferase reporter assay confirmed downstream targets miRNA, xenograft demonstrated efficacy miRNA. The level observed increase KYSE180 KYSE140 ESCC cells following ADAR1 treatment. Following editing, function progression underwent reversal, shifting from carcinogenic inhibitory. Wild‐type (WT) IRS1, whereas version ROR2. WT miR‐1304‐3p, but not version, suppressed tumor‐suppressive effect IRS1 ESCC. Conversely, ROR2, specific target acted as tumor promoter Furthermore, can inhibit glycolysis inactivate Wnt5a/ROR2 signaling pathway alters by changing its gene. hinders development inhibiting inactivating pathway.
Язык: Английский
Процитировано
0Pharmacology & Therapeutics, Год журнала: 2025, Номер unknown, С. 108798 - 108798
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0Molecular Biology Reports, Год журнала: 2025, Номер 52(1)
Опубликована: Март 3, 2025
Язык: Английский
Процитировано
0